Evofem Biosciences, Inc. provided sales guidance for the third quarter of 2023. For the expects sales to be $5.0 million to $5.2 million for the third quarter of 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0136 USD | -2.52% | -2.86% | -78.75% |
1st Jan change | Capi. | |
---|---|---|
-78.75% | 827K | |
+33.43% | 700B | |
+27.42% | 569B | |
-5.12% | 358B | |
+19.59% | 330B | |
+4.89% | 287B | |
+16.15% | 236B | |
+6.66% | 202B | |
-9.49% | 197B | |
+4.26% | 161B |
- Stock Market
- Equities
- EVFM Stock
- News Evofem Biosciences, Inc.
- Evofem Biosciences, Inc. Provides Sales Guidance for the Third Quarter of 2023